Vγ2Vδ2 T lymphocyte-based immunotherapy

· Shanghai Pulmonary Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vγ2Vδ2 T lymphocyte-based immunotherapy, covering 2022-08-10 to 2022-08-10. Get the full timeline:

Most recent: Clinical Trial Update: A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB [Phase 4]